Drug · DIN 02269341
KIVEXA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since November 11, 2025; first marketed August 17, 2005.
- Drug Identification Number (DIN)
- 02269341
- Company (DIN owner)
- Viiv Healthcare UlcMontreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Lamivudine and abacavir J05AR02
- Class
- Human
- Record last updated
- December 9, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ABACAVIR (ABACAVIR SULFATE) | 600 MG | |
| LAMIVUDINE | 300 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 21, 2013: NOC 14482New Drug Submission (NDS) · Administrative transfer of Drug Identification Number
- August 18, 2010: NOC 11663New Drug Submission (NDS) · Manufacturer name change
- December 21, 2009: NOC 10883New Drug Submission (NDS) · Manufacturer name change
- December 24, 2008: NOC 9970New Drug Submission (NDS) · Manufacturer name change
- July 25, 2005: NOC 7263New Drug Submission (NDS)